Publications
Showing all 48 journal articles & 2 books available
Journal Articles
2017
Lin F, Ren P, Lo Y, Chapman B, Jacobs A, Baran T, Porsteinsson AP, Foxe J. "Insula and Inferior Frontal Gyrus' Activations Protect Memory Performance Against Alzheimer's Pathology in Old Age. ." J Alzheimers Dis. 2017; 55(2): 669-678.
2017
Lin F, Ren P, Mapstone M, Meyers S, Porsteinsson AP, Baran TM. "The Cingulate Cortex of Older Adults with Excellent Memory Capacity". Cortex. 2017; : 83-92.
5/2016
Leonpacher A, Peters ME, Drye LT, Makino KM, Newell J, Devanand DP, Frangakis C, Mintzer JE, Munro CA, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP: For the CitAD Research Group. "Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence from the CitAD Study". Am J Psychiatry. 2016; 173(5): 473-80.
5/2016
Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano C, Mintzer JE, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade DM, Weintraub D, Yesavage J, and Lyketsos CG, for the CitAD Research Group. "Heterogeneity of Treatment Response to Citalopram for Alzheimer Disease Patients with Aggression or Agitation: The CitAD Randomized Clinical Trial." Am J Psychiatry. 2016; 173(5): 465-72.
2016
Rosenberg PB; Lanctot KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R. "Changes in Neuropsychiatric Inventory associated with semagestat treatment of Alzheimer's disease." J Alzheimers Disease. 2016; 54(1): 373-81.
2016
Lin F, Heffner K, Tivarus M, Ren P, Brasch J, Chen D, Mapstone M, Porsteinsson AP, and Tadin D. "Cognitive and Neural Effects of Vision-Based Speed of Processing Training in Older Adults with Mild Cognitive Impairment: A pilot study". J Am Geriatr Soc. 2016; 64(6): 1293-8.
2016
Peters ME, Vaidya V, Drye LT, Devanand DP, Mintzer JE, Pollock BG, Porsteinsson AP, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, MD8, Lyketsos CG, and Avramopoulos D: For the CitAD Research Group. "Citalopram for the Treatment of Agitation in Alzheimer's Dementia: Genetic Influences." J Geriatr Psychiatry Neurol. 2016; 29(2): 59-64.
2016
Chapman R, Gardner MN, Mapstone M, Klorman R, Porsteinsson AP, Dupree HM, Antonsdottir IM, Kamalyan L. "ERP C250 Shows the Elderly (Cognitively Normal, Alzheimer's Disease) Store More Stimuli in Short-Term Memory than Young Adults Do." Clinical Neurophysiology 127. 2016; : 2423–2435.
2016
David N, Lin F, Porsteinsson AP. "Trajectories of neuropsychiatric symptoms and cognitive decline in mild cognitive impairment." Am J Geriatr Psychiatry. 2016; 24(1): 70-80.
2016
Antonsdottir IM, Makino KM, Porsteinsson AP. "Dazed and Confused - Medical Cannabis in Alzheimer's Disease." Am J Geriatr Psychiatry. 2016; 24(11): 1004-06.
2016
Abushakra S, Porsteinsson AP, Vellas B, et al. "Clinical Benefit of Tramiprosate in AD are associated with higher number of APOE4 alleles: "The Gene-Dose Effect"". J Prev Alz Dis. 2016; 3(4): 219-228.
2015
Rosenberg PB; Drye LT; Porsteinsson AP; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Schneider LS; Shade DM; Weintraub D; Newell J; Yesavage J; and Lyketsos CG, for the CitAD Research Group. "Change in Agitation in Alzheimer's disease in the placebo arm of a 9-week controlled trial." Int Psychogeriatric. 2015; 27(12): 2059-67.
2015
Weintraub D, Drye LT, Porsteinsson AP, Rosenberg PB, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Schneider LS, Shade DM, Yesavage J, and Lyketsos CG, for the CitAD Research Group. "Time to response to citalopram treatment for agitation in Alzheimer's disease". Am J Geriatr Psychiatry. 2015; 23(11): 1127-33.
2015
Cummings J, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PN, and Siffert J, for the 12-AVR-131 Study Group. "Dextromethorphan/Quinidine (DM/Q) for Agitation/Aggression in Alzheimer's Disease Dementia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial". JAMA. 2015; 314(12): 1242-1254.
3/15/2010
Profenno LA, Porsteinsson AP, Faraone SV. "Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders." Biological psychiatry.. 2010 Mar 15; 67(6):505-12. Epub 2009 Apr 09.
2010
Chapman, AP.; Mapstone, M.; McCrary, J.W.; Gardner, M.N.; Porsteinsson, A.P. "Predicting Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Neuropsychological Tests and Multivariate Methods." Journal of Clinical and Experimental Neuropsychology. 2010; 13: 1-13.
11/18/2008
Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Nessly ML, . "Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial." Neurology.. 2008 Nov 18; 71(21):1702-8.
7/2008
, Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M. "Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib." Archives of neurology.. 2008 Jul; 65(7):896-905. Epub 2008 May 12.
7/2008
Streim JE, Porsteinsson AP, Breder CD, Swanink R, Marcus R, McQuade R, Carson WH. "A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2008 Jul; 16(7):537-50.
2/2008
Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT, . "Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial." Current Alzheimer research.. 2008 Feb; 5(1):83-9.
2/2007
Cosman KM, Boyle LL, Porsteinsson AP. "Memantine in the treatment of mild-to-moderate Alzheimer's disease." Expert opinion on pharmacotherapy.. 2007 Feb; 8(2):203-14.
11/2006
Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG. "Design of Depression in Alzheimer's Disease Study-2." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2006 Nov; 14(11):920-30.
2/28/2006
Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC. "Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease." Neurology.. 2006 Feb 28; 66(4):602-4.
2006
Porsteinsson AP. "Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly." Drugs & aging.. 2006 23(11):877-86.
12/2005
Profenno LA, Jakimovich L, Holt CJ, Porsteinsson A, Tariot PN. "A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease." Current Alzheimer research.. 2005 Dec; 2(5):553-8.
11/2005
Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L, , . "Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2005 Nov; 13(11):942-9.
2/2005
Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG, . "Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'." International journal of geriatric psychiatry.. 2005 Feb; 20(2):119-27.
2004
Porsteinsson AP; Ismail MS. "Memantine – A Novel Therapeutic Option for Alzheimer's Disease." Today's Therapeutic Trends. 2004; 22(1): 17-28.
8/2003
Schneider LS, Porsteinsson AP, Peskin ER, Pfeiffer EA. "Choosing treatment for Alzheimer's patients and their caregivers." Geriatrics.. 2003 Aug; 58 Suppl 1:3-18, 23; quiz 19-22.
2003
Porsteinsson AP, Tariot PN, Jakimovich LJ, Kowalski N, Holt C, Erb R, Cox C. "Valproate therapy for agitation in dementia: open-label extension of a double-blind trial." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2003 11(4):434-40.
2003
Tune LE, Porsteinsson A, Weinberg A. "Dementia management: regulations, rules, and research." Journal of the American Medical Directors Association.. 2003 4(4 Suppl):H13-6.
12/7/2002
Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S. "Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales." Advanced drug delivery reviews.. 2002 Dec 7; 54(12):1567-77.
9/2002
Nelson JC, Tune LE, Daiello LA, Porsteinsson A. "Interactive grand rounds: mood stabilizers in dementia." Geriatrics.. 2002 Sep; 57(9):suppl 2-5.
5/2001
Tariot PN, Ryan JM, Porsteinsson AP, Loy R, Schneider LS. "Pharmacologic therapy for behavioral symptoms of Alzheimer's disease." Clinics in geriatric medicine.. 2001 May; 17(2):359-76.
4/2001
Noviasky JA, Porsteinsson AP, Lee YH. "Second generation anticonvulsant medications: their use in children." The Journal of school nursing : the official publication of the
National Association of School Nurses. 2001 Apr; 17(2):103-11.
2001
Porsteinsson AP, Tariot PN, Erb R, Cox C, Smith E, Jakimovich L, Noviasky J, Kowalski N, Holt CJ, Irvine C. "Placebo-controlled study of divalproex sodium for agitation in dementia." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 2001 9(1):58-66.
6/27/2000
Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C. "A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group." Neurology.. 2000 Jun 27; 54(12):2269-76.
2000
Caine ED; Porsteinsson A; Lyness JM; First M;. "Reconsidering the DSM-IV diagnoses of Alzheimer's disease: behavioral and psychological symptoms in patients". International Psychogeriatrics. 2000; 12(1): 23-27.
10/1997
Porsteinsson AP, Tariot PN, Schneider LS. "Mood Disturbances in Alzheimer's Disease." Seminars in clinical neuropsychiatry.. 1997 Oct; 2(4):265-275.
6/1997
Tariot PN, Schneider L, Porsteinsson AP. "Treating Alzheimer's disease. Pharmacologic options now and in the near future." Postgraduate medicine.. 1997 Jun; 101(6):73-6, 81, 84 passim.
1997
Porsteinsson, A.; Duberstein, P.; Conwell, Y.; Cox, C.; Forbes, N.; Caine, E.D. "Suicide and Alcoholism: Distinguishing Alcoholics with and without Comorbid Drug Abuse." American Journal of Addictions. 1997; 6: 304-310.
1997
Porsteinsson AP, Tariot PN, Erb R, Gaile S. "An open trial of valproate for agitation in geriatric neuropsychiatric disorders." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.. 1997 5(4):344-51.
1997
Porsteinsson A, Duberstein PR, Conwell Y, Cox C, Forbes N, Caine ED. "Suicide and alcoholism. Distinguishing alcoholic patients with and without comorbid drug abuse." The American journal on addictions. 1997 6(4):304-10.
1997
Tariot P, Gaile SE, Castelli NA, Porsteinsson AP. "Treatment of agitation in dementia." New directions for mental health services. 1997 (76):109-23.
10/1996
Woolf PD, Nichols D, Porsteinsson A, Boulay R. "Thyroid evaluation of hospitalized psychiatric patients: the role of TSH screening for thyroid dysfunction." Thyroid : official journal of the American Thyroid Association.. 1996 Oct; 6(5):451-6.
1996
Tariot PN; Teri L; Porsteinsson A; Weiner;. "Measurement of Behavioral Disturbance in Chronic Care Populations." Journal of Mental Health Aging. 1996; 2(3): 213-229.
Mohs RC, Shiovitz TM, Tariot PN, Porsteinsson AP, Baker KD, Feldman PD. "Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Alzheimer's Disease." Neurology.
Boyle LL; Porsteinsson AP; Cui X; King DA; Lyness JM. "Depression and Cognitive Disorders in Older Primary Care Patients." Journal of Clinical Psychiatry.